Patents by Inventor Ferenc Scheeren

Ferenc Scheeren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10273454
    Abstract: The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: April 30, 2019
    Assignee: ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM
    Inventors: Hergen Spits, Ferenc A. Scheeren, Tim Beaumont, Sean A. Diehl
  • Patent number: 9822339
    Abstract: The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: November 21, 2017
    Assignees: ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM, AIMM THERAPEUTICS B.V.
    Inventors: Hergen Spits, Ferenc A. Scheeren, Tim Beaumont, Sean A. Diehl
  • Publication number: 20170306293
    Abstract: The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.
    Type: Application
    Filed: June 2, 2017
    Publication date: October 26, 2017
    Inventors: HERGEN SPITS, FERENC A. SCHEEREN, TIM BEAUMONT, SEAN A. DIEHL
  • Publication number: 20160060598
    Abstract: The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.
    Type: Application
    Filed: August 26, 2015
    Publication date: March 3, 2016
    Inventors: Hergen Spits, Ferenc A. Scheeren, Tim Beaumont, Sean A. Diehl
  • Patent number: 9127251
    Abstract: The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: September 8, 2015
    Assignees: ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM, AIMM THERAPEUTICS B.V.
    Inventors: Hergen Spits, Ferenc A. Scheeren, Tim Beaumont, Sean A. Diehl
  • Patent number: 8389281
    Abstract: The invention provides methods for maintaining cell lines from primary cells, i.e., non-transformed cells, using expression of the signal transducer of activation and transcription (STAT). The methods are particularly suitable for maintenance of B-cells.
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: March 5, 2013
    Assignee: Cancer Research Technology Limited
    Inventors: Hergen Spits, Marianne Naspetti, Ferenc Scheeren, Bianca Blom
  • Patent number: 8318487
    Abstract: The invention provides methods for maintaining cell lines from primary cells, i.e. non-transformed cells, using expression of the signal transducer of activation and transcription (STAT). The methods are particularly suitable for the maintenance of B-cells.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: November 27, 2012
    Assignee: Cancer Research Technology Limited
    Inventors: Hergen Spits, Marianne Naspetti, Ferenc Scheeren, Bianca Blom
  • Publication number: 20100113745
    Abstract: The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.
    Type: Application
    Filed: December 8, 2006
    Publication date: May 6, 2010
    Applicant: Meibergdreef 9
    Inventors: Hergen Spits, Ferenc A. Scheeren, Sean A. Diehl
  • Publication number: 20090275139
    Abstract: The invention provides methods for maintaining cell lines from primary cells, i.e., non-transformed cells, using expression of the signal transducer of activation and transcription (STAT). The methods are particularly suitable for maintenance of B-cells.
    Type: Application
    Filed: April 28, 2009
    Publication date: November 5, 2009
    Inventors: Hergen Spits, Marianne Naspetti, Ferenc Scheeren, Bianca Blom
  • Publication number: 20060153820
    Abstract: The invention provides methods for maintaining cell lines from primary cells, i.e. non-transformed cells, using expression of the signal transducer of activation and transcription (STAT). The methods are particularly suitable for the maintenance of B-cells.
    Type: Application
    Filed: December 18, 2002
    Publication date: July 13, 2006
    Inventors: Hergen Spits, Marianne Naspetti, Ferenc Scheeren, Bianca Blom